Dr. John McHutchison of Assembly Biosciences, Inc. is a familiar name if you’ve heard about the recent advancements in the treatment of chronic hepatitis. Above all, the company has done a great deal to develop unique; however, much-needed therapeutics targeting diseases related to the microbiome.
Other companies are playing a crucial role in producing enormous trials. For instance, ongoing research in brain cancer treatment.
READ MORE: Powerful Trials for Brain Cancer Treatment – Efforts of Quadriga BioSciences
The CEO of the company, Dr. John McHutchison, has been awarded the Global Impact Award of 2020 due to his and his company’s efforts to devise therapy options for hepatitis patients. Therefore, Dr. McHutchison holds this recognition as a valuable asset to the world.